Tag - novartis

 
 

NOVARTIS

An employee looks at data on screens in the high-tech command center at the Novartis AG campus in Basel, Switzerland.
BUSINESS / Companies
Jan 10, 2024
Swiss pharma firms plot different paths to blockbuster drugs
Roche has doubled down on Alzheimer’s and boosted research and development spending across its portfolio.
Japan Times
WORLD / Science & Health
Jun 3, 2023
Breast cancer drug shown to reduce recurrence risk
Even when the disease is caught early, breast cancer recurrence is relatively common — and for survivors, the prospect can be daunting.
Japan Times
BUSINESS / Companies
Nov 25, 2019
Novartis agrees to buy Medicines Co. in $6.8 billion deal targeting promising cholesterol drug
Novartis AG agreed to buy Medicines Co. for an equity value of about $6.8 billion, snapping up a promising cholesterol drug and adding to a string of acquisitions for Chief Executive Officer Vas Narasimhan.
Japan Times
BUSINESS
Aug 8, 2019
Novartis says it knew of Zolgensma data problems before U.S. approval
Swiss Drugmaker Novartis AG on Wednesday said it knew about discrepancies in data it submitted to regulators as it sought approval of its more than $2 million gene therapy Zolgensma, but delayed notifying authorities until it completed an internal investigation.
BUSINESS
May 10, 2018
Novartis ends contract with firm linked to Trump lawyer Michael Cohen, calling ties a mistake
Swiss drugmaker Novartis has ended a contract with a firm linked to U.S. President Donald Trump's lawyer, Michael Cohen, saying it was now seen as a mistake.
Japan Times
JAPAN / Science & Health / A MATTER OF HEALTH
Nov 15, 2017
Japanese doctor who exposed a drug too good to be true calls for morality and reforms
It was a gut feeling and common sense that made Dr. Iwao Kuwajima question a drug for high blood pressure that just about every other doctor in his field was excited about in the 2000s.
BUSINESS
Sep 11, 2017
Novartis posts win, Roche a flop in drug trials targeting skin cancer
Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche with slipping sales failed in a separate study with a similar patient group.
WORLD / Science & Health
Jul 9, 2015
Progress reported in using gene therapy for deafness
Gene therapy for deafness is moving closer to reality, with new research on Wednesday showing the technique for fixing faulty DNA can improve responses in mice with genetic hearing loss.
EDITORIALS
Sep 4, 2014
Novartis drug probe falls short
The Tokyo criminal probe into the manipulation of clinical data pertaining to the efficacy of a Novartis Pharma-marketed drug for blood pressure has failed to unravel the whole picture of the scandal.
Japan Times
JAPAN
Feb 27, 2014
Diovan scandal traced to cozy doctor-drugmaker ties
The manipulation of clinical research data used to develop the blood pressure drug Diovan sold by Novartis Pharma K.K. has prompted a special squad of Tokyo prosecutors to search the Japanese unit of the Swiss drugmaker as well as the universities that conducted the research.
Japan Times
JAPAN / EXPLAINER
Jan 13, 2014
Novartis drug's data-tampering reflects unchecked collusion
Last week, the Health, Labor and Welfare Ministry filed a criminal complaint with prosecutors against Novartis Pharma K.K., the Japanese subsidiary of Swiss pharmaceutical giant Novartis, alleging the firm made exaggerated advertising claims for its blockbuster blood pressure drug Diovan.

Longform

Sociologist Gracia Liu-Farrer argues that even though immigration doesn't figure into Japan's autobiography, it is more of a self-perception than a reality.
In search of the ‘Japanese dream’